Clorox Co. (NYSE:CLX) announced a quarterly dividend on Tuesday, September 13th. Shareholders of record on Wednesday, October 26th will be paid a dividend of 0.80 per share on Monday, November 14th. This represents a $3.20 annualized dividend and a yield of 2.63%. The ex-dividend date of this dividend is Monday, October 24th.
Shares of Clorox (NYSE:CLX) opened at 121.80 on Wednesday. Clorox has a 52 week low of $119.23 and a 52 week high of $140.47. The firm has a market capitalization of $15.77 billion, a P/E ratio of 24.76 and a beta of 0.30. The firm has a 50-day moving average of $124.81 and a 200 day moving average of $129.64.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.28 by $0.02. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The company earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the prior year, the company posted $1.44 earnings per share. The business’s revenue was up 2.8% compared to the same quarter last year. On average, equities research analysts expect that Clorox will post $5.49 EPS for the current fiscal year.
Several equities analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating in a report on Tuesday, July 12th. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and set a $131.00 target price (up from $125.00) on shares of Clorox in a research note on Friday, July 15th. Deutsche Bank AG reaffirmed a “hold” rating and set a $134.00 target price (up from $130.00) on shares of Clorox in a research note on Sunday, July 24th. Citigroup Inc. upped their target price on shares of Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a research note on Monday, August 8th. Finally, B. Riley reaffirmed a “neutral” rating and set a $109.00 target price on shares of Clorox in a research note on Tuesday, August 9th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $127.80.
In related news, EVP Laura Stein sold 38,882 shares of Clorox stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total value of $5,120,370.58. Following the sale, the executive vice president now owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Nikolaos A. Vlahos sold 925 shares of Clorox stock in a transaction that occurred on Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total value of $123,089.75. The disclosure for this sale can be found here. 0.74% of the stock is owned by corporate insiders.
A number of large investors have recently made changes to their positions in the stock. Valley National Advisers Inc. raised its stake in shares of Clorox by 0.6% in the second quarter. Valley National Advisers Inc. now owns 845 shares of the company’s stock worth $117,000 after buying an additional 5 shares in the last quarter. Wetherby Asset Management Inc. raised its position in Clorox by 1.0% in the second quarter. Wetherby Asset Management Inc. now owns 2,408 shares of the company’s stock valued at $333,000 after buying an additional 25 shares during the period. Burney Co. raised its position in Clorox by 1.3% in the second quarter. Burney Co. now owns 5,783 shares of the company’s stock valued at $800,000 after buying an additional 74 shares during the period. Advisor Partners LLC raised its position in Clorox by 4.4% in the second quarter. Advisor Partners LLC now owns 2,087 shares of the company’s stock valued at $289,000 after buying an additional 87 shares during the period. Finally, Advantus Capital Management Inc raised its position in Clorox by 0.8% in the second quarter. Advantus Capital Management Inc now owns 12,777 shares of the company’s stock valued at $1,768,000 after buying an additional 100 shares during the period. 70.20% of the stock is currently owned by institutional investors and hedge funds.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.